Siemens Healthineers and HeartFlow Collaborate to Provide Solution that Has Potential to Lower Cardiac Care Costs

Siemens HealthineersSiemens Healthineers and HeartFlow, Inc. have entered into a global collaboration agreement to provide a comprehensive, noninvasive solution to support the diagnosis and management of patients with suspected coronary artery disease (CAD). HeartFlow is a pioneer in personalized medical technology to aid in the diagnosis and treatment of CAD. Siemens Healthineers aims to enable healthcare providers to meet current challenges and excel in their respective environments. To execute this strategy in the field of cardiology, Siemens Healthineers is collaborating with HeartFlow and contributing its strength in computed tomography (CT).

The collaboration's joint solution pairs CT scanners from Siemens Healthineers, which provide excellent image quality, with the HeartFlow FFRct Analysis, the first noninvasive technology to provide insight into both the extent of coronary artery disease and the impact that disease has on blood flow to the heart.

Using CT images, the HeartFlow FFRct Analysis creates a personalized 3D model of each patient's arteries; computer algorithms then simulate blood flow and assess the impact of arterial blockages. The combined clinical pathway of coronary CT angiography (cCTA) and the HeartFlow FFRct Analysis offers actionable information that helps physicians determine each patient's optimal course of treatment. Published clinical data(1) demonstrate that use of the HeartFlow FFRct Analysis may prevent unnecessary invasive angiograms.

Although the United States is the initial commercial focus of this collaboration agreement, the two companies plan to expand their efforts to additional geographic markets in the future.

"It is a fact that the treatment planning for coronary artery disease patients can be improved via quantitative data out of FFR measurements. With our exciting partnership between Siemens Healthineers and HeartFlow, Inc., we create an integrated solution that combines the exceptional cCTA images acquired by our high performance scanners with the only commercial product available that can derive FFR analysis noninvasively from CT data," said André Hartung, Head of Computed Tomography at Siemens Healthineers.

"HeartFlow is pleased to collaborate with Siemens Healthineers, with its outstanding technology, tremendous expertise, and global reach," said John H. Stevens, MD, chairman and CEO of HeartFlow. "Like HeartFlow, Siemens Healthineers is deeply committed to helping clinicians improve the patient experience and clinical outcomes while also helping them to reduce the total cost of healthcare. By working together, we can ensure this technology gets to every patient who can benefit from it."

1. Douglas, P.S., DeBruyne, B., Pontone, G., Patel, MR, et al. (2016). 1-Year Outcomes of FFRCT-Guided Care in Patients with Suspected Coronary Disease: The PLATFORM Study. J Am Coll Cardiol, 68(5), 435-45.

About Siemens Healthineers
Siemens Healthineers is the separately managed healthcare business of Siemens AG enabling healthcare providers worldwide to meet their current challenges and to excel in their respective environments. A leader in medical technology, Siemens Healthineers is constantly innovating its portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. Siemens Healthineers is also actively developing its digital health services and enterprise services. To help customers succeed in today's dynamic healthcare marketplace, Siemens Healthineers is championing new business models that maximize opportunity and minimize risk for healthcare providers. In fiscal 2016, which ended on September 30, 2016, Siemens Healthineers generated revenue of €13.5 billion and net income of over €2.3 billion and has about 46,000 employees worldwide.

About HeartFlow, Inc.
HeartFlow, Inc. is a personalized medical technology company seeking to transform the way cardiovascular disease is diagnosed and treated. The company's HeartFlow FFRct Analysis is the first available non-invasive solution that enables a physician to more accurately evaluate whether a patient has significant coronary artery disease (CAD) based on both anatomy and physiology. The solution, which leverages deep learning to create a personalized 3D model of the patient's arteries, is well positioned to become an integral part of the standard of care for patients who are at risk for CAD because of its potential to improve clinical outcomes, improve the patient experience and reduce the cost of care. The HeartFlow FFRct Analysis is available in the United States, Canada, Europe and Japan.

Most Popular Now

Which Self-Help Websites Actually Improv…

From depression to weight loss, insomnia to cutting back on alcohol or cigarettes, the Internet teems with sites that promise to help people improve their health. Which of these really...

Read more

Facial Recognition Software Helps Diagno…

Researchers with the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, and their collaborators, have successfully used facial recognition software to diagnose a rare, genetic...

Read more

AbedGraham and Highland Marketing Partne…

Global efforts to enhance clinical engagement and accelerate the impact of digital technology in improving patient care, will be boosted by a new bilateral relationship between two organisations dedicated to...

Read more

eHealth Hub: Call for the First Lean Sta…

The Lean Startup Academy is an unique opportunity to mature your business by systematically testing your ideas against the market with the support of experts. The course will help you...

Read more

Medtec Europe 2017: Discover the Latest …

4 - 6 April 2017, Stuttgart, Germany. Medtec Europe will once again provide over 7,000 attendees and more than 600 exhibitors from 70 countries the opportunity to share, learn, and discover...

Read more

Highland Marketing Recruits Strategy and…

PR and marketing agency Highland Marketing has appointed Lyn Whitfield to the new post of strategy and content director. Whitfield is a journalist by background, who has specialised in writing...

Read more

The Grants4Apps® Accelerator Berlin 2017

The Grants4Apps® Accelerator is a mentoring program for digital health startups taking place in Berlin. This year's batch with five startups runs from September until November. The program offers mentoring...

Read more

Philips and PathAI Team Up to Improve Br…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and PathAI, a company that develops artificial intelligence technology for pathology, are collaborating with the aim to develop...

Read more

Health 2.0 Europe 2017

3 - 5 May 2017, Barcelona, Spain. The 8th edition of Health 2.0 Europe will take place in Barcelona in a new location: Fira Montjuic, Plaza España. Health 2.0 Europe will...

Read more

Biased Bots: Human Prejudices Sneak into…

In debates over the future of artificial intelligence, many experts think of the new systems as coldly logical and objectively rational. But in a new study, researchers have demonstrated how...

Read more

Allscripts Announces dbMotionTM Solution…

Allscripts (NASDAQ:MDRX) announced today that its Community interoperability platform, dbMotion Solution, is now available through the cloud via Microsoft Azure. The cloud-based solution offers the same capabilities as the on-premise...

Read more

Public Funding Essential for Advances in…

In the budget President Trump recently submitted to Congress, he asked for a reduction in the 2018 funding of the U.S. National Institutes of Health (NIH) of almost 20 percent...

Read more
(HEALTH IT) SPACE - Take a look at who has just Joined